Difference between revisions of "Part:BBa K1723005"
 
(5 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
<partinfo>BBa_K1723005 short</partinfo>
 
<partinfo>BBa_K1723005 short</partinfo>
  
−
<b/>PAM rich URS J23117Alt is a new fully synthetic promoter obtained by mutation of PAM rich URS J23117 promoter (BBa_K1723001)</b>. It acts the exactly same way as the PAM rich URS J23117 promoter but is targeted by others specific sgRNAS. See the design section for more information about its creation. It has PAM (PAM = NGG sequence) rich Upstream Regulatory Sequence to enable the use of protein dCas9-&#969; (BBa_K1723000) as a gene transcription regulator when in complex with one sgRNA targeting the promoter such as: X0 (BBa_K1723006), X4 (BBa_K1723007), or X35 (BBa_K1723008). dCas9 can only bind in presence of a PAM sequence.
+
<b>PAM rich URS J23117Alt is a new fully synthetic promoter obtained by mutating a model promoter [2], PAM rich URS J23117 promoter (BBa_K1723001) [1]</b>. It acts the exactly same way as the PAM rich URS J23117 promoter but is targeted by others specific sgRNAS. See the design section for more information about its creation. It has PAM (PAM = NGG sequence) rich Upstream Regulatory Sequence to enable the use of protein dCas9-&#969; (BBa_K1723000), that can only bind in presence of a PAM sequence, as a gene transcription regulator, when in complex with one sgRNA targeting the promoter such as: inhibiting sgRNA X0 (BBa_K1723006), activating sgRNA X4 (BBa_K1723007), or inhibiting sgRNA X35 (BBa_K1723008).  
  
−
Discover all the parts that can work with this one:
+
<b>This part was experimentally validated, see </b> https://parts.igem.org/Part:BBa_K1723005:Experience
 +
 
 +
Discover more parts that can work with this one:
  
 
http://2015.igem.org/Team:EPF_Lausanne/Part_Collection
 
http://2015.igem.org/Team:EPF_Lausanne/Part_Collection
Line 17: Line 19:
 
<partinfo>BBa_K1723005 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K1723005 SequenceAndFeatures</partinfo>
  
 +
===References===
 +
 +
[1] Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic acids research, 41(15), 7429-7437.
 +
 +
[2] Alec AK Nielsen & Christopher A Voigt (2014). Multi-input CRISPR/Cas circuits that interface host regulatory network. Molecular systems biology, 10(11), 763.
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  

Latest revision as of 00:48, 19 September 2015

PAM rich URS J23117Alt promoter

PAM rich URS J23117Alt is a new fully synthetic promoter obtained by mutating a model promoter [2], PAM rich URS J23117 promoter (BBa_K1723001) [1]. It acts the exactly same way as the PAM rich URS J23117 promoter but is targeted by others specific sgRNAS. See the design section for more information about its creation. It has PAM (PAM = NGG sequence) rich Upstream Regulatory Sequence to enable the use of protein dCas9-ω (BBa_K1723000), that can only bind in presence of a PAM sequence, as a gene transcription regulator, when in complex with one sgRNA targeting the promoter such as: inhibiting sgRNA X0 (BBa_K1723006), activating sgRNA X4 (BBa_K1723007), or inhibiting sgRNA X35 (BBa_K1723008).

This part was experimentally validated, see https://parts.igem.org/Part:BBa_K1723005:Experience

Discover more parts that can work with this one:

http://2015.igem.org/Team:EPF_Lausanne/Part_Collection

EPFL_Lausanne_promoter.png

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 277
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 167
    Illegal XhoI site found at 195
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

References

[1] Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013). Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic acids research, 41(15), 7429-7437.

[2] Alec AK Nielsen & Christopher A Voigt (2014). Multi-input CRISPR/Cas circuits that interface host regulatory network. Molecular systems biology, 10(11), 763.